EPRX

Eupraxia Pharmaceuticals
EPRX

11 hedge funds and large institutions have $7.09M invested in Eupraxia Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

0.92% more ownership

Funds ownership: 5.13% → 6.05% (+0.92%)

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$556K
2
+$362K
3
+$206K
4
UBS Group
UBS Group
Switzerland
+$80.1K
5
Citadel Advisors
Citadel Advisors
Florida
+$41.6K

Top Sellers

1
-$33.3K
2
-$31.3K
3
-$15.5K
4
Raymond James Financial
Raymond James Financial
Florida
-$1.66K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$5.07M
2
$1.13M
3
$343K
4
$171K
5
$168K
6
$113K
7
$39.4K
8
$36.5K
9
$8.86K
10
$8.2K
11
$2.49K
12
–
13
–